• Product name

    Anti-BAFF-R antibody [EPR14633]
    See all BAFF-R primary antibodies
  • Description

    Rabbit monoclonal [EPR14633] to BAFF-R
  • Host species

  • Tested applications

    Suitable for: IHC-Pmore details
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Recombinant fragment within Human BAFF-R aa 100 to the C-terminus. The exact sequence is proprietary.
    Database link: Q96RJ3

  • Positive control

    • Human colon and tonsil tissues.
  • General notes



    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.


  • Form

  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    Preservative: 0.01% Sodium azide
    Constituents: 40% Glycerol, 0.05% BSA, 59% PBS
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

  • Clone number

  • Isotype

  • Research areas


Our Abpromise guarantee covers the use of ab188868 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/250 - 1/500. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.


  • Function

    B-cell receptor specific for TNFSF13B/TALL1/BAFF/BLyS. Promotes the survival of mature B-cells and the B-cell response.
  • Tissue specificity

    Highly expressed in spleen and lymph node, and in resting B-cells. Detected at lower levels in activated B-cells, resting CD4+ T-cells, in thymus and peripheral blood leukocytes.
  • Involvement in disease

    Defects in TNFRSF13C are the cause of immunodeficiency common variable type 4 (CVID4) [MIM:613494]; also called antibody deficiency due to BAFFR defect. CVID4 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B cells is usually in the normal range, but can be low.
  • Sequence similarities

    Contains 1 TNFR-Cys repeat.
  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • B cell activating factor receptor antibody
    • B-cell-activating factor receptor antibody
    • BAFF R antibody
    • BAFF receptor antibody
    • BAFF-R antibody
    • BAFFR antibody
    • BLyS receptor 3 antibody
    • BlySR3 antibody
    • BR 3 antibody
    • BR3 antibody
    • BROMIX antibody
    • CD 268 antibody
    • CD268 antibody
    • CD268 antigen antibody
    • CVID4 antibody
    • MGC138235 antibody
    • OTTHUMP00000028746 antibody
    • Prolixin antibody
    • TNFRSF 13C antibody
    • Tnfrsf13c antibody
    • TR13C_HUMAN antibody
    • Tumor necrosis factor receptor subunit member 13C antibody
    • Tumor necrosis factor receptor superfamily member 13C antibody
    see all


  • Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling BAFF-R with ab188868 at 1/250 dilution followed by pre-diluted HRP Polymer for Rabbit IgG secondary antibody and counter-stained with Hematoxylin.

  • Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling BAFF-R with ab188868 at 1/500 dilution followed by pre-diluted HRP Polymer for Rabbit IgG secondary antibody and counter-stained with Hematoxylin.


ab188868 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab188868.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact partnerships@abcam.com

Sign up